<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSX</journal-id>
<journal-id journal-id-type="hwp">sprsx</journal-id>
<journal-id journal-id-type="nlm-ta">Reprod Sci</journal-id>
<journal-title>Reproductive Sciences</journal-title>
<issn pub-type="ppub">1933-7191</issn>
<issn pub-type="epub">1933-7205</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1933719111417888</article-id>
<article-id pub-id-type="publisher-id">10.1177_1933719111417888</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>MTHFR</italic> C677T Polymorphism and Recurrent Early Pregnancy Loss Risk in North Indian Population</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nair</surname>
<given-names>Rohini R.</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="aff1-1933719111417888">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khanna</surname>
<given-names>Anuradha</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-1933719111417888">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Singh</surname>
<given-names>Kiran</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1933719111417888">1</xref>
<xref ref-type="corresp" rid="corresp1-1933719111417888"/>
</contrib>
</contrib-group>
<aff id="aff1-1933719111417888">
<label>1</label>Department of Molecular &amp; Human Genetics, Banaras Hindu University, Varanasi, India</aff>
<aff id="aff2-1933719111417888">
<label>2</label>Department of Obstetrics &amp; Gynaecology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India</aff>
<author-notes>
<corresp id="corresp1-1933719111417888">Kiran Singh, Department of Molecular &amp; Human Genetics, Banaras Hindu University, Varanasi 221005, India Email: <email>singhk4@rediffmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>19</volume>
<issue>2</issue>
<fpage>210</fpage>
<lpage>215</lpage>
<permissions>
<copyright-statement>© Society for Gynecologic Investigation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society for Gynecologic Investigation</copyright-holder>
</permissions>
<abstract>
<p>Recurrent early pregnancy loss (REPL) is a multifactorial disorder as both genetic and environmental factors contribute to the development of disease. Folate metabolism is an important mechanism to ensure proper fetal growth. Hyperhomocysteinemia leads to a number of disorders and REPL is one of them. In a case–control study DNA from 106 cases with the history of 3 or more REPL and 140 healthy fertile controls with successful pregnancy outcomes were genotyped for C677T single-nucleotide polymorphism (SNP) of the <italic>MTHFR</italic> (methylenetetrahydrofolate reductase) gene through polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP), which was further confirmed by sequencing. Allele frequencies of REPL cases were compared with healthy controls and a statistically significant association was found between REPL and the mutant T allele (χ<sup>2</sup> = 8.786, odds ratio [OR] = 2.20, 95% confidence interval [CI] = 1.323-3.9658, <italic>P = </italic>.003). The genotype frequencies of SNP C677T also differ significantly between these 2 groups (χ<sup>2</sup> = 8.237, <italic>P </italic>= .016). The OR for heterozygous CT in the REPL versus controls is 1.9591 (95% CI = 1.0285-3.7318, <italic>P </italic>= .04). The OR for TT homozygous is 6.3009 (95% CI = 1.2065, <italic>P</italic> = .02). Combined odds ratio of CT and TT against the control has been calculated as 2.2194 (95% CI = 1.2029-4.0952, <italic>P </italic>= .02) which is also significant. Thus the present study clearly indicates that homozygosity and heterozygosity for the <italic>MTHFR </italic>C677T polymorphism confer a 6.3009- and 1.9591-fold increased risk of idiopathic REPL, respectively.</p>
</abstract>
<kwd-group>
<kwd>recurrent early pregnancy loss</kwd>
<kwd>C677T SNP</kwd>
<kwd>hyperhomocysteinemia</kwd>
<kwd>angiogenesis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1933719111417888">
<title>Introduction</title>
<p>Recurrent early pregnancy loss (REPL) is a multifactorial disorder which includes coagulation disorders, autoimmune defects, endocrine disorders, and endometrial defects.<sup>
<xref ref-type="bibr" rid="bibr1-1933719111417888">1</xref>
</sup> In all, 50% cases of REPL are idiopathic with no known factors. Approximately 5% of couples trying to conceive have 2 consecutive miscarriages and approximately 1% of couples have 3 or more consecutive losses.</p>
<p>Proper development of blood vessel in the maternal and fetal interface is required for the exchange of nutrients, gases, and other metabolites through the extra-embryonic coelomic cavity via yolk sac to the embryo.<sup>
<xref ref-type="bibr" rid="bibr2-1933719111417888">2</xref>
</sup> Folate metabolism is considered an imperative mechanism for proper fetal development and successful fetal outcome. Vitamin B deficiency can also result in mild hyperhomocysteinemia. Elevated homocysteine concentration is considered a cause for defective chorionic villi vascularization.<sup>
<xref ref-type="bibr" rid="bibr3-1933719111417888">3</xref>
</sup> One of the causative factors associated with REPL is the aberrant expression of angiogenesis-related genes in the maternal–fetal interface resulting in improper development of embryo.<sup>
<xref ref-type="bibr" rid="bibr4-1933719111417888">4</xref>
</sup> Homocysteine inhibits endothelial cell proliferation, which is closely related to angiogenesis. MTHFR (methylenetetrahydrofolate reductase) enzyme is known to maintain the level of homocysteine in the blood.<sup>
<xref ref-type="bibr" rid="bibr5-1933719111417888">5</xref>
</sup> Increased level of homocysteine in the blood acts as risk factor for a number of disorders which include atherosclerosis, venous thrombosis, neural tube defects, placental abruption or infarction, preeclampsia and so on.<sup>
<xref ref-type="bibr" rid="bibr6-1933719111417888">6</xref>
<xref ref-type="bibr" rid="bibr7-1933719111417888"/>
<xref ref-type="bibr" rid="bibr8-1933719111417888"/>
<xref ref-type="bibr" rid="bibr9-1933719111417888"/>–<xref ref-type="bibr" rid="bibr10-1933719111417888">10</xref>
</sup> Hyperhomocysteinemia has also been found to be associated with the risk of REPL in a population of the Netherland.<sup>
<xref ref-type="bibr" rid="bibr11-1933719111417888">11</xref>
</sup>
</p>
<p>MTHFR converts homocysteine into methionine, the precursor of <italic>S</italic>-adenosylmethionine which is a universal donor of methyl group for DNA methylation.<sup>
<xref ref-type="bibr" rid="bibr12-1933719111417888">12</xref>
</sup> DNA methylation plays an important role in gene expression. Abnormal activity of this enzyme can be thought to affect the vascularization and impair the development of embryo.<sup>
<xref ref-type="bibr" rid="bibr3-1933719111417888">3</xref>
</sup> However, a small study reported the toxic effect on embryo rather than affecting methylation.<sup>
<xref ref-type="bibr" rid="bibr13-1933719111417888">13</xref>
</sup> In normal first trimester pregnancies low extra-embryonic coelomic total homocysteine concentration and high folate and methionine concentrations have been reported.<sup>
<xref ref-type="bibr" rid="bibr3-1933719111417888">3</xref>
</sup> MTHFR catalyses the reduction of 5,10-methylenetetrahydrolate to 5-methyltetrahydrofolate. 5-Methyltetrahydrofolate converts homocysteine to methionine.<sup>
<xref ref-type="bibr" rid="bibr5-1933719111417888">5</xref>
</sup> The C677T polymorphism of <italic>MTHFR</italic> gene affects the enzyme activity.<sup>
<xref ref-type="bibr" rid="bibr14-1933719111417888">14</xref>,<xref ref-type="bibr" rid="bibr15-1933719111417888">15</xref>
</sup> <italic>MTHFR</italic> 677 TT genotype carriers have approximately 30% of the enzyme activity in vitro as compared with the <italic>MTHFR</italic> 677 CC genotype, and <italic>MTHFR</italic> 677 CT genotype shows nearly 65% of normal enzyme activity.<sup>
<xref ref-type="bibr" rid="bibr14-1933719111417888">14</xref>
</sup>
</p>
<p>In the present study, we have evaluated the association between maternal genotype of single-nucleotide polymorphism (SNP) C677T of <italic>MTHFR</italic> gene and REPL. We hypothesized that a genotype associated with a decreased activity of <italic>MTHFR</italic> could be linked with impaired/incomplete angiogenesis which may lead to REPL phenotype.</p>
</sec>
<sec id="section2-1933719111417888">
<title>Materials and Methods</title>
<sec id="section3-1933719111417888">
<title>Participants</title>
<p>The present study enrolled 123 primary aborter women who had 3 or more trimester miscarriages before 12 weeks of gestation and 140 healthy fertile women with successful pregnancy outcome as controls. Patients were recruited from the outpatient department of university hospital, Department of Obstetrics &amp; Gynaecology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Patients underwent a standardized clinical and laboratory evaluation which included hysteroscopy, paternal and maternal karyotyping, cervical cultures for chlamydia, plasma urea, mycoplasma, a comprehensive hormonal status for hypothyroidism (T3, T4, and thyroid-stimulating hormone [TSH]) and evaluation of antiphospholipid syndrome with anti-β2GP1 antibodies, immunoglobulins M and G, anticardiolipin antibody(ACLA) assessment, and lupus anticoagulant testing. Solid-phase enzyme-linked immunosorbent assay (ELISA) was used for assay and the value greater than 10 1 unit IgG phospholipid (GPL) was considered ACLA positive. In all, 17 patients during their clinical and laboratory investigations showed 1 or the other known anomalies and were excluded. Among them 4 represented polycystic ovaries, 3 were ACLA positive, 1 was both LA and ACLA positive, 4 were Toxoplasmosis Other Rubella Cytomegalovirus and Herpes (TORCH) positive, 1 was having cervical incompetency, 1 with arcuate uterus, 1 with septate uterus, and 1 had hypothyroidism. Karyotype analysis revealed 2 patients with abnormal numerical chromosome complement. Two patients had mosaic (46, XX and 45, XO) karyotype. Remaining 106 REPL patients having regular cycles were included in the present study. Patients positive for the above test were excluded from the study. None of them had pregnancy-related complications such as diabetes or hypertension. An age-matched 140 women with no history of previous miscarriage and at least 1 successful pregnancy outcome and no problem of cardiovascular disease were selected as controls for the study. All controls were also recruited from the same outpatient department of university hospital. Questionnaire was maintained for each patient to the record details of their lifestyle, habits, and family history. Informed consent was obtained from every participant in each group before their participation in the study. Approval of the University’s ethical committee for research on human material was obtained.</p>
</sec>
<sec id="section4-1933719111417888">
<title>Karyotyping</title>
<p>Blood lymphocyte culture was done for each patient and patients showing abnormal chromosome complement were excluded.</p>
</sec>
<sec id="section5-1933719111417888">
<title>Genotyping of SNP MTHFR C677T by PCR-RFLP</title>
<p>Genomic DNA was extracted from peripheral blood of 106 patients with 46, XX karyotype (2 patients whose karyotype showed numerical chromosomal abnormality were excluded) using standard salting-out procedure. The PCR amplification of <italic>MTHFR</italic> C667T mutation region was amplified using previously used primer with forward primer (5′-AGGCTGTGCTGTGCTGTTG-3′) and reverse primer (5′-CGCTCTGCAAGTTCTGGA-3′) by PCR.<sup>
<xref ref-type="bibr" rid="bibr16-1933719111417888">16</xref>
</sup> The PCR conditions were 30 cycles of 1 minute at 94°C, 1 minute at 68°C, and 1 minute at 72°C. The 477 base pair (bp) fragment generated was restricted digested with <italic>Hin</italic>f1 at 37°C for 15 hours. The C allele is cut by the enzyme and gives 425 bp and 52 bp products, whereas the T allele yields 260 bp, 165 bp, and 52 bp products (<xref ref-type="fig" rid="fig1-1933719111417888">Figure 1</xref>).</p>
<fig id="fig1-1933719111417888" position="float">
<label>Figure 1.</label>
<caption>
<p>
<italic>M<bold>THFR</bold>
</italic> C677T mutation was detected by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP). The 477 base pair (bp) was digested with <italic>Hin</italic>f1. The C allele is cut by the enzyme and yields 425 bp, 52 bp products, whereas the T allele yields a 425 bp, 260 bp, 165 bp, and 52 bp products. Lane 1 shows the 100-bp ladder (New England Biolabs), lanes 2, 3, and 4: CC homozygous; lanes 5 and 6: TT homozygous; lanes 7 and 8: CT heterozygous.</p>
</caption>
<graphic alternate-form-of="fig1-1933719111417888" xlink:href="10.1177_1933719111417888-fig1.tif"/>
</fig>
</sec>
<sec id="section6-1933719111417888">
<title>Sequencing</title>
<p>The PCR product of mutant TT genotype was sequenced with <italic>Taq-Dye</italic> deoxy-terminator-cycle sequencing kit (Applied Biosystem, California) using an automated genetic analyzer 3130 sequencer to ascertain polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) results (<xref ref-type="fig" rid="fig2-1933719111417888">Figure 2</xref>). Reverse primer was used for cycle sequencing. The sequence was aligned and analyzed using AB DNA Sequencing Analysis software (version 5.2).</p>
<fig id="fig2-1933719111417888" position="float">
<label>Figure 2.</label>
<caption>
<p>Sequencing chromatogram showing the 3 genotypes of single-nucleotide polymorphism (SNP) C677T of <italic>MTHFR</italic> gene. Reverse primer was used for sequencing on the genetic analyzer 3130 automated sequencer. The SNP at position C677T of <italic>MTHFR</italic> is represented by ⋆. (A) Represent homozygous mutant TT, (B) heterozygous CT, and (C) homozygous wild type CC.</p>
</caption>
<graphic alternate-form-of="fig2-1933719111417888" xlink:href="10.1177_1933719111417888-fig2.tif"/>
</fig>
</sec>
<sec id="section7-1933719111417888">
<title>Statistical Analysis</title>
<p>Allele and genotype distribution among groups were evaluated using chi-square (χ<sup>
<xref ref-type="bibr" rid="bibr2-1933719111417888">2</xref>
</sup>) test or Fisher exact test. The difference in frequencies between the case and control groups was analyzed for statistical significance at the 95% confidence interval (CI) using χ<sup>
<xref ref-type="bibr" rid="bibr2-1933719111417888">2</xref>
</sup> test. The allele frequency of <italic>MTHFR</italic> genotype was in Hardy-Weinberg equilibrium. Odds ratios (ORs) were calculated and reported within the 95% confidence limits. A <italic>P</italic> value of &lt;.05 was considered significant in all the analyses. Power of study was calculated using G* power.<sup>
<xref ref-type="bibr" rid="bibr17-1933719111417888">17</xref>,<xref ref-type="bibr" rid="bibr18-1933719111417888">18</xref>
</sup>
</p>
</sec>
</sec>
<sec id="section8-1933719111417888">
<title>Results</title>
<p>In the present study blood lymphocyte culture and G-banding was done for each patient to analyze chromosomal abnormalities. Two patients showed abnormal numerical chromosome complement. Both had mosaic (46, XX and 45, XO) karyotype, hence both the patients were excluded from the study and their DNA was not subjected for genotyping. The PCR-RFLP analysis was performed to evaluate the genotypes of C677T polymorphism of <italic>MTHFR</italic> gene in 106 patients and 140 control samples (<xref ref-type="fig" rid="fig1-1933719111417888">Figure 1</xref>). The power of study was found to be 0.99. The genotype and allele frequencies for C677T polymorphism in the <italic>MTHFR</italic> gene were compared between the 2 groups (<xref ref-type="table" rid="table1-1933719111417888">Table 1</xref>). For <italic>MTHFR</italic> C677T polymorphism, T allele frequency in REPL patients was 0.16% and in controls 0.082%. The allele and genotype frequencies of <italic>MTHFR</italic> C677T genotype were in Hardy-Weinberg equilibrium. We found homozygosity for the <italic>MTHFR </italic>C677T polymorphism confers a 6.3009-fold increased risk of idiopathic REPL. Allele frequencies of the C677T polymorphism showed statistically significant difference between the REPL versus control group (χ<sup>
<xref ref-type="bibr" rid="bibr2-1933719111417888">2</xref>
</sup> = 8.786, OR = 2.20, 95% CI = 1.323-3.9658, <italic>P = </italic>.003). The genotype frequencies of SNP C677T also differ significantly between these 2 groups (χ<sup>
<xref ref-type="bibr" rid="bibr2-1933719111417888">2</xref>
</sup> = 8.237, <italic>P </italic>= .016). The OR for heterozygous CT in the REPL versus controls is 1.9591 (95% CI = 1.0285-3.7318, <italic>P </italic>= .04). For TT homozygous, the OR was 6.3009 (95% CI = 1.2065, <italic>P</italic> = .02). Combined OR of CT and TT against the control has been calculated to 2.2194 (95% CI = 1.2029-4.0952, <italic>P </italic>= .02) which is also significant. Thus the above result indicates the role of <italic>MTHFR</italic> C677T SNP in the development of REPL phenotype and it can be used as one of the biomarker in patients having the history of REPL. Early screening of patients with mutant genotypes (677TT and 677CT) and by exogenous folic acid supplementation, the adverse effect of enzymatic deficiency can be reversed. This may prevent fetal loss and lead to successful pregnancy outcome at least in cases where MTHFR enzyme activity deficiency is a critical player.</p>
<table-wrap id="table1-1933719111417888" position="float">
<label>Table 1.</label>
<caption>
<p>Genotype and allele frequencies of <italic>MTHFR</italic> C677T single-nucleotide polymorphism (SNP) among REPL and control groups</p>
</caption>
<graphic alternate-form-of="table1-1933719111417888" xlink:href="10.1177_1933719111417888-table1.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Case</th>
<th>Control</th>
<th>Odds Ratio</th>
<th>95% CI</th>
<th>
<italic>P </italic>value</th>
</tr>
</thead>
<tbody>
<tr>
<td>n</td>
<td align="center">106</td>
<td align="center">140</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>Genotype CC</td>
<td>75 (70.75)</td>
<td>118 (84.29)</td>
<td>1.0</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>CT</td>
<td>26 (24.53)</td>
<td>21 (15)</td>
<td>1.9591</td>
<td>1.0285-3.731</td>
<td>.04</td>
</tr>
<tr>
<td>TT</td>
<td>5 (4.72)</td>
<td>1 (0.71)</td>
<td>6.3009</td>
<td>1.2065-32.90</td>
<td>.02</td>
</tr>
<tr>
<td>CT and TT</td>
<td align="center">31</td>
<td align="center">23</td>
<td>2.2194</td>
<td>1.202-4.095</td>
<td>.02</td>
</tr>
<tr>
<td>Alleles (n)</td>
<td align="center">212</td>
<td align="center">280</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>C</td>
<td>176 (84%)</td>
<td>257 (91.8%)</td>
<td>2.20</td>
<td>1.323-3.965</td>
<td>.003</td>
</tr>
<tr>
<td>T</td>
<td>36 (16%)</td>
<td>23 (8.2%)</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1933719111417888">
<p>Abbreviation: REPL, recurrent early pregnancy loss.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section9-1933719111417888">
<title>Discussion</title>
<p>In this study, we have undertaken a case–control study to investigate the role of <italic>MTHFR </italic>C677T polymorphisms in susceptibility to REPL in north Indian population. Our study demonstrates strong association of <italic>MTHFR</italic> C677T polymorphism and REPL. Both cases and controls belonged to the same ethnic background and all shared a common geographic origin, that is north India. MTHFR is the candidate enzyme known to play a crucial role in the methyl group metabolic pathway which is involved in both DNA methylation and DNA synthesis.<sup>
<xref ref-type="bibr" rid="bibr5-1933719111417888">5</xref>
</sup> Hyperhomocysteinemia has been found to have an embryotoxic effect rather than affecting methylation.<sup>
<xref ref-type="bibr" rid="bibr13-1933719111417888">13</xref>
</sup> However, it is also suggested that hyperhomocysteinemia resulted in thrombophilia by circulating monocytes inducing the expression of tissue factor, an initiator of blood coagulation in vivo.<sup>
<xref ref-type="bibr" rid="bibr19-1933719111417888">19</xref>
</sup> Hyperhomocysteinemia is also thought<sup>
<xref ref-type="bibr" rid="bibr20-1933719111417888">20</xref>
</sup> to affect endothelial cell function by promoting leukocyte recruitment which contributes to the initiation and progression of vascular disease through upregulation of the expression and secretion of monocytes chemoattractant protein 1 and interleukin 8.</p>
<p>Our result is consistent with the number of studies done, which suggest the role of C677T SNP of <italic>MTHFR</italic> gene and REPL risk.<sup>
<xref ref-type="bibr" rid="bibr8-1933719111417888">8</xref>,<xref ref-type="bibr" rid="bibr21-1933719111417888">21</xref>
<xref ref-type="bibr" rid="bibr22-1933719111417888"/>
<xref ref-type="bibr" rid="bibr23-1933719111417888"/>
<xref ref-type="bibr" rid="bibr24-1933719111417888"/>
<xref ref-type="bibr" rid="bibr25-1933719111417888"/>–<xref ref-type="bibr" rid="bibr26-1933719111417888">26</xref>
</sup> Histological evidence suggests the placid effect of <italic>MTHFR </italic>C677T on the risk of placental infarction with fetal growth restriction.<sup>
<xref ref-type="bibr" rid="bibr21-1933719111417888">21</xref>
<xref ref-type="bibr" rid="bibr22-1933719111417888"/>
<xref ref-type="bibr" rid="bibr23-1933719111417888"/>
<xref ref-type="bibr" rid="bibr24-1933719111417888"/>–<xref ref-type="bibr" rid="bibr25-1933719111417888">25</xref>
</sup> The role of MTHFR on placental abruption and/or infarction has been confirmed in a meta-analysis of 8 studies.<sup>
<xref ref-type="bibr" rid="bibr8-1933719111417888">8</xref>
</sup> The association of idiopathic recurrent pregnancy loss and <italic>MTHFR</italic> has been studied in Middle-European white population.<sup>
<xref ref-type="bibr" rid="bibr26-1933719111417888">26</xref>
</sup> They found that homozygosity for the <italic>MTHFR </italic>C677T polymorphism confers a 3.7-fold increased risk of idiopathic recurrent pregnancy loss. They also found that carriers of 1 or 2 mutant alleles had significantly higher serum concentrations of homocysteine compared with women with 2 wild type alleles. A similar study in accordance with the present study reported an increased prevalence of the C677T mutation in a cohort of Dutch women with a history of unexplained recurrent pregnancy loss.<sup>
<xref ref-type="bibr" rid="bibr27-1933719111417888">27</xref>
</sup> They found a 3-fold increased risk of recurrent pregnancy loss in women homozygous for the <italic>MTHFR </italic>T&gt;T genotype. Similarly other groups found an association of <italic>MTHFR</italic> and recurrent pregnancy loss.<sup>
<xref ref-type="bibr" rid="bibr28-1933719111417888">28</xref>,<xref ref-type="bibr" rid="bibr29-1933719111417888">29</xref>
</sup> No association was found in other study between <italic>MTHFR</italic> 677T&gt;T genotype and idiopathic RPL.<sup>
<xref ref-type="bibr" rid="bibr30-1933719111417888">30</xref>
<xref ref-type="bibr" rid="bibr31-1933719111417888"/>
<xref ref-type="bibr" rid="bibr32-1933719111417888"/>
<xref ref-type="bibr" rid="bibr33-1933719111417888"/>–<xref ref-type="bibr" rid="bibr34-1933719111417888">34</xref>
</sup> It has also been found that homozygosity for <italic>MTHFR</italic> C677T results in pregnancy loss and other prothrombotic factors act as an additional risk factor.<sup>
<xref ref-type="bibr" rid="bibr28-1933719111417888">28</xref>
</sup>
</p>
<p>
<italic>MTHFR</italic> polymorphism and its association with recurrent pregnancy loss have also been studied in Indian population but in endogamous group that is among Rajput of North India<sup>
<xref ref-type="bibr" rid="bibr35-1933719111417888">35</xref>
</sup> and in group of women of Andhra Pradesh<sup>
<xref ref-type="bibr" rid="bibr36-1933719111417888">36</xref>
</sup> (pilot study). <italic>MTHFR</italic> C677T polymorphism showed almost 4.7-fold increased risk of recurrent pregnancy loss in the Rajput population of north India. Mutant genotypes (TT/CT) could have a significant influence on the metabolic phenotype because of very low folate and high homocysteine level in the Indian populations.<sup>
<xref ref-type="bibr" rid="bibr37-1933719111417888">37</xref>,<xref ref-type="bibr" rid="bibr38-1933719111417888">38</xref>
</sup> Selective advantage of <italic>MTHFR</italic> C allele might be physiologically protective and presence of T allele would put the individual at metabolic risk in an Indian population.<sup>
<xref ref-type="bibr" rid="bibr39-1933719111417888">39</xref>
</sup> <italic>MTHFR</italic> CC genotype may favor normal placentation and vessel development which is crucial for proper exchange of nutrient from mother to fetus. Improper maternal–fetal exchange in patients with <italic>MTHFR</italic> TT and CT mutant genotypes because of compromised angiogenesis, improper placentation, and vessel development may ultimately lead to fetal loss. It was also found in animal model study that supplementation of folic acid during the early trimester of pregnancy increased the survival of fetus and also the number of fetus.<sup>
<xref ref-type="bibr" rid="bibr40-1933719111417888">40</xref>,<xref ref-type="bibr" rid="bibr41-1933719111417888">41</xref>
</sup> Hence, in patients with TT/CT genotype, the folic acid supplementation may improve successful pregnancy outcome.</p>
</sec>
<sec id="section10-1933719111417888">
<title>Conclusion</title>
<p>We conclude that the T allele is significantly associated with the development of idiopathic REPL in a north Indian population. Folic acid supplementation has been found to improve fetal survival in animal model. Hence, it can be exogenously supplemented to improve the survival of fetus in mothers having mutant 677TT and 677CT genotypes. Therefore, the present study signifies the role of C677T SNP of folate metabolic pathway in the development of REPL phenotype. Keeping in view the significant role of <italic>MTHFR</italic> in vascularization and development of placenta, we suggest that 677C&gt;T SNP of <italic>MTHFR</italic> gene may be examined as one of the markers for REPL.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We are thankful to all the patients and volunteers for providing blood samples.</p>
</ack>
<fn-group>
<fn fn-type="other" id="fn1-1933719111417888">
<p>This work was done at the Department of Molecular &amp; Human Genetics, Banaras Hindu University, Varanasi-221005, India.</p>
</fn>
<fn fn-type="conflict" id="fn2-1933719111417888">
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-1933719111417888">
<p>Financial assistance was provided by Department of Biotechnology, Ministry of Science and Technologyy, New Delhi, India.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1933719111417888">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laird</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Tuckerman</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Cork</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Linjawi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Blakemore</surname>
<given-names>AIF</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>TC</given-names>
</name>
</person-group>. <article-title>A review of immune cells and molecules in women with recurrent miscarriage</article-title>. <source>Hum Reprod Update</source>. <year>2003</year>;<volume>9</volume>(<issue>2</issue>):<fpage>163</fpage>–<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr2-1933719111417888">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Extalo</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Early human nutrition</article-title>. <source>Eur J Obstet Gyn R B</source>. <year>1995</year>;<volume>61</volume>:<fpage>3</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr3-1933719111417888">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelen</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Bulten</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Steegers</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Blom</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Hanselaar</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Eskes</surname>
<given-names>TK</given-names>
</name>
</person-group>. <article-title>Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss</article-title>. <source>Hum Reprod</source>. <year>2000</year>;<volume>15</volume>(<issue>4</issue>):<fpage>954</fpage>–<lpage>960</lpage>.</citation>
</ref>
<ref id="bibr4-1933719111417888">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Baek</surname>
<given-names>KH</given-names>
</name>
</person-group>. <article-title>Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy patients</article-title>. <source>Mol Reprod Dev</source>. <year>2003</year>;<volume>66</volume>(<issue>1</issue>):<fpage>24</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr5-1933719111417888">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bailey</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement</article-title>. <source>J Nutr</source>. <year>1999</year>;<volume>129</volume>(<issue>5</issue>):<fpage>919</fpage>–<lpage>922</lpage>.</citation>
</ref>
<ref id="bibr6-1933719111417888">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wenstrom</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Johanning</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Amniotic fluid homo-cysteine levels, 5,10-methylenetetrahydrafolate reductase genotypes, and neural tube closure sites</article-title>. <source>Am J Med Genet</source>. <year>2000</year>;<volume>90</volume>(<issue>1</issue>):<fpage>6</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr7-1933719111417888">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Trudinger</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Duarte</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wilcken</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
</person-group>. <article-title>Elevated circulating homocyst(e)ine levels in placental vascular disease and associated pre-eclampsia</article-title>. <source>BJOG</source>. <source>2000</source>;<volume>107</volume>(<issue>7</issue>):<fpage>935</fpage>–<lpage>938</lpage>.</citation>
</ref>
<ref id="bibr8-1933719111417888">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Laskin</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review</article-title>. <source>Placenta</source>. <year>1999</year>;<volume>20</volume>(<issue>7</issue>):<fpage>519</fpage>–<lpage>529</lpage>.</citation>
</ref>
<ref id="bibr9-1933719111417888">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sohda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arinami</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hamada</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hamaguchi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Methylenetetrahydrofolate reductase polymorphism and pre-ecla psia</article-title>. <source>J Med Genet</source>. <year>1997</year>;<volume>34</volume>(<issue>6</issue>):<fpage>525</fpage>–<lpage>526</lpage>.</citation>
</ref>
<ref id="bibr10-1933719111417888">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCully</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Chemical pathology of homocysteine. II. Carcinogenesis and homocysteine thiolactone metabolism</article-title>. <source>Ann Clin Lab Sci</source>. <year>1994</year>;<volume>24</volume>(<issue>1</issue>):<fpage>27</fpage>–<lpage>59</lpage>.</citation>
</ref>
<ref id="bibr11-1933719111417888">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wouters</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Boers</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Blom</surname>
<given-names>HJ</given-names>
</name>
<etal/>
</person-group> <article-title>Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss</article-title>. <source>Fertil Steril</source>. <year>1993</year>;<volume>60</volume>(<issue>5</issue>):<fpage>820</fpage>–<lpage>825</lpage>.</citation>
</ref>
<ref id="bibr12-1933719111417888">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>Association of polymorphisms in folate metabolic genes and prostate Cancer risk: a case–control study in a Chinese population</article-title>. <source>J Genet</source>. <year>2010</year>;<volume>89</volume>(<issue>2</issue>):<fpage>263</fpage>–<lpage>267</lpage>.</citation>
</ref>
<ref id="bibr13-1933719111417888">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obwegeser</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sinzinger</surname>
<given-names>HM</given-names>
</name>
</person-group>. <article-title>Homocysteine—a pathophysiological cornerstone in obstetrical and gynaecological disorders?</article-title> <source>Hum Reprod Update</source>. <year>1999</year>;<volume>5</volume>(<issue>1</issue>):<fpage>64</fpage>–<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr14-1933719111417888">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frosst</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Blom</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Milos</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase</article-title>. <source>Nat Genet</source>. <year>1995</year>;<volume>10</volume>(<issue>1</issue>):<fpage>111</fpage>–<lpage>113</lpage>.</citation>
</ref>
<ref id="bibr15-1933719111417888">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weisberg</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sibani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rozen</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity</article-title>. <source>Mol.Genet Metab</source>. <year>1998</year>;<volume>64</volume>(<issue>3</issue>):<fpage>169</fpage>–<lpage>172</lpage>.</citation>
</ref>
<ref id="bibr16-1933719111417888">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mostowska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hozyasz</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Wojcicki</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dziegelewska</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jagodzinski</surname>
<given-names>PP</given-names>
</name>
</person-group>. <article-title>Associations of folate and choline metabolism gene polymorphisms with orofacial clefts</article-title>. <source>J Med Genet</source>. <year>2009</year>;<volume>47</volume>(<issue>12</issue>):<fpage>809</fpage>–<lpage>815</lpage>. <comment>DOI: 10.1136/jmg.2009.070029</comment>.</citation>
</ref>
<ref id="bibr17-1933719111417888">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faul</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Erdfelder</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Buchner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>AG</given-names>
</name>
</person-group>. <article-title>Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses</article-title>. <source>Behav Res Methods</source>. <year>2009</year>;<volume>41</volume>(<issue>4</issue>):<fpage>1149</fpage>–<lpage>1160</lpage>.</citation>
</ref>
<ref id="bibr18-1933719111417888">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faul</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Erdfelder</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Buchner</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences</article-title>. <source>Behav Res Methods</source>. <year>2007</year>;<volume>39</volume>(<issue>2</issue>):<fpage>175</fpage>–<lpage>191</lpage>.</citation>
</ref>
<ref id="bibr19-1933719111417888">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fryer</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Gubler</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Rodgers</surname>
<given-names>GM</given-names>
</name>
</person-group>. <article-title>Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells</article-title>. <source>Arterioscler Thromb</source>. <year>1993</year>;<volume>13</volume>(<issue>9</issue>):<fpage>1327</fpage>–<lpage>1333</lpage>.</citation>
</ref>
<ref id="bibr20-1933719111417888">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poddar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sivasubramanian</surname>
<given-names>N</given-names>
</name>
<name>
<surname>DiBello</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>DW</given-names>
</name>
</person-group>. <article-title>Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease</article-title>. <source>Circulation</source>. <year>2001</year>;<volume>103</volume>(<issue>22</issue>):<fpage>2717</fpage>–<lpage>2723</lpage>.</citation>
</ref>
<ref id="bibr21-1933719111417888">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hefler</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jirecek</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heim</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group> <article-title>Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine fetal death: a multicenter study</article-title>. <source>J Soc Gynecol Investig</source>. <year>2004</year>;<volume>11</volume>(<issue>1</issue>):<fpage>42</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr22-1933719111417888">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rey</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>David</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shrier</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Thrombophilic disorders and fetal loss: a meta-analysis</article-title>. <source>Lancet</source>. <year>2003</year>;<volume>361</volume>(<issue>9361</issue>):<fpage>901</fpage>–<lpage>908</lpage>.</citation>
</ref>
<ref id="bibr23-1933719111417888">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>August</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Genetic thrombophilias and preeclampsia: a meta-analysis</article-title>. <source>Obstet Gynecol</source>. <year>2005</year>;<volume>105</volume>(<issue>1</issue>):<fpage>182</fpage>–<lpage>192</lpage>.</citation>
</ref>
<ref id="bibr24-1933719111417888">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tempfer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schneeberger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Riener</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Hefler</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Keck</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Polymorphisms for risk assessment of pregnancy-associated disorders: review of the literature and meta-analysis</article-title>. <source>Geburtsh Frauenheilk</source>. <year>2004</year>;<volume>64</volume>(<issue>10</issue>):<fpage>1080</fpage>–<lpage>1089</lpage>.</citation>
</ref>
<ref id="bibr25-1933719111417888">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van der Molen</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Arends</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Nelen</surname>
<given-names>WL</given-names>
</name>
<etal/>
</person-group> <article-title>A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy</article-title>. <source>Am J Obstet Gynecol</source>. <year>2000</year>;<volume>182</volume>(<issue>5</issue>):<fpage>1258</fpage>–<lpage>1263</lpage>.</citation>
</ref>
<ref id="bibr26-1933719111417888">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unfried</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Griesmacher</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Weismuller</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Nagele</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Tempfer</surname>
<given-names>CB</given-names>
</name>
</person-group>. <article-title>The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage</article-title>. <source>Obstet Gynecol</source>. <year>2002</year>;<volume>99</volume>(<issue>4</issue>):<fpage>614</fpage>–<lpage>619</lpage>.</citation>
</ref>
<ref id="bibr27-1933719111417888">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelen</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Steegers</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Eskes</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Blom</surname>
<given-names>HJ</given-names>
</name>
</person-group>. <article-title>Genetic risk factor for unexplained recurrent early pregnancy loss</article-title>. <source>Lancet</source>. <year>1997</year>;<volume>350</volume>(<issue>9081</issue>):<fpage>861</fpage>.</citation>
</ref>
<ref id="bibr28-1933719111417888">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quere</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bellet</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hoffet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Janbon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mares</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gris</surname>
<given-names>JC</given-names>
</name>
</person-group>. <article-title>A woman with five consecutive fetal deaths: case report and retrospective analysis of hyperhomocysteinaemia prevalence in 100 consecutive women with recurrent miscarriages</article-title>. <source>Fertil Steril</source>. <year>1998</year>;<volume>69</volume>(<issue>1</issue>):<fpage>152</fpage>–<lpage>154</lpage>.</citation>
</ref>
<ref id="bibr29-1933719111417888">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarig</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Younis</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lanir</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Blumenfeld</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage</article-title>. <source>Fertil Steril</source>. <year>2002</year>;<volume>77</volume>(<issue>2</issue>):<fpage>342</fpage>–<lpage>347</lpage>.</citation>
</ref>
<ref id="bibr30-1933719111417888">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foka</surname>
<given-names>ZJ</given-names>
</name>
<name>
<surname>Lambropoulos</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Saravelos</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group> <article-title>Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages</article-title>. <source>Hum Reprod</source>. <year>2000</year>;<volume>15</volume>(<issue>2</issue>):<fpage>458</fpage>–<lpage>462</lpage>.</citation>
</ref>
<ref id="bibr31-1933719111417888">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sugiura-Ogasawara</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Suzumori</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Suzumori</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>No association of C677T methylenetetrahydrofolate reductase and an endothelial nitric oxide synthase polymorphism with recurrent pregnancy loss</article-title>. <source>Am J Reprod Immunol</source>. <year>2004</year>;<volume>52</volume>(<issue>1</issue>):<fpage>60</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr32-1933719111417888">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kutteh</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Deitcher</surname>
<given-names>SR</given-names>
</name>
</person-group>. <article-title>Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss</article-title>. <source>Fertil Steril</source>. <year>1999</year>;<volume>71</volume>(<issue>6</issue>):<fpage>1048</fpage>–<lpage>1053</lpage>.</citation>
</ref>
<ref id="bibr33-1933719111417888">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carp</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Salomon</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Seidman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dardik</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Inbal</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss</article-title>. <source>Hum Reprod</source>. <year>2002</year>;<volume>17</volume>(<issue>6</issue>):<fpage>1633</fpage>–<lpage>1637</lpage>.</citation>
</ref>
<ref id="bibr34-1933719111417888">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biswas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Choudhry</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mittal</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Recurrent abortions in Asian Indians: no role of factor V Leiden Hong Kong/Cambridge mutation and MTHFR polymorphism</article-title>. <source>Clin Appl Thromb Hemost</source>. <year>2008</year>;<volume>4</volume>(<issue>1</issue>):<fpage>102</fpage>–<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr35-1933719111417888">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukhopadhyay</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Saraswathy</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>PK</given-names>
</name>
</person-group>. <article-title>MTHFR C677T and factor V Leiden in recurrent pregnancy loss: a study among an endogamous group in north India</article-title>. <source>Genet Test Mol Biomarkers</source>. <year>2009</year>;<volume>13</volume>(<issue>6</issue>):<fpage>861</fpage>–<lpage>865</lpage>.</citation>
</ref>
<ref id="bibr36-1933719111417888">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>KSD</given-names>
</name>
<name>
<surname>Govindaiah</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Naushad</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Devi</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Jyothy</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Plasma homocysteine levels correlated to interactions between folate status and methylene tetrahydrofolate reductase gene mutation in women with unexplained recurrent pregnancy loss</article-title>. <source>J Obstet Gynecol</source>. <year>2003</year>;<volume>23</volume>(<issue>1</issue>):<fpage>55</fpage>–<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr37-1933719111417888">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lakshmi</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Maniprabha</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Krishna</surname>
<given-names>TP</given-names>
</name>
</person-group>. <article-title>Plasma homocysteine level in relation to folate and vitamin B6 status in apparently normal men</article-title>. <source>Asia</source> <source>Pac J Clin Nutr</source>. <year>2001</year>;<volume>10</volume>(<issue>3</issue>):<fpage>194</fpage>–<lpage>196</lpage>.</citation>
</ref>
<ref id="bibr38-1933719111417888">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Refsum</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yajnik</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Gadkari</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Hyperhomocysteinaemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians</article-title>. <source>Am J Clin Nutr</source>. <year>2001</year>;<volume>74</volume>(<issue>2</issue>):<fpage>233</fpage>–<lpage>241</lpage>.</citation>
</ref>
<ref id="bibr39-1933719111417888">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Sah</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Raman</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Mutation C677T in the methylenetetrahydrofolate reductase gene is associated with male infertility in an Indian population</article-title>. <source>Int J Androl</source>. <year>2005</year>;<volume>28</volume>(<issue>2</issue>):<fpage>115</fpage>–<lpage>119</lpage>.</citation>
</ref>
<ref id="bibr40-1933719111417888">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Habibzadeh</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Schorah</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Smithells</surname>
<given-names>RW</given-names>
</name>
</person-group>. <article-title>The effects of maternal folic acid and vitamin C nutrition in early pregnancy on reproductive performance in the guinea-pig</article-title>. <source>Br J Nutr</source>. <year>1986</year>;<volume>55</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr41-1933719111417888">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremblay</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Matte</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Dufour</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Brisson</surname>
<given-names>GJ</given-names>
</name>
</person-group>. <article-title>Survival rate and development of fetuses during the first 30 days of gestation after folic acid addition to a swine diet</article-title>. <source>J Anim Sci</source>. <year>1989</year>;<volume>67</volume>(<issue>3</issue>):<fpage>724</fpage>–<lpage>732</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>